Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Remogliflozin etabonate | 442201-24-3 | MFCD17167013 | 99.8% | 522.59 | C26H38N2O9 | 10 MG
Supplier: Medchemexpress LLC HY1494510MG
Remogliflozin etabonate is an orally active prodrug that is metabolized to remogliflozin, a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor used in preclinical antidiabetic research. In rodent studies it increases urinary glucose excretion, lowers fasting plasma glucose and glycated hemoglobin, and can suppress hypertriglyceridemia.
- Selective SGLT2 inhibition for antidiabetic research.
- Orally active prodrug metabolized to the active glucoside.
- High purity (~99.8%) for reproducible experimental results.
- White to off-white solid, suitable for handling and storage.
- Available in small laboratory quantities for in vitro and in vivo studies.
- Documented efficacy in multiple rodent models.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?